Mullerian inhibiting substance levels and ovarian response

Details for Australian Patent Application No. 2002324756 (hide)

Owner The General Hospital Corporation University of Medicine and Dentistry of New Jersey

Inventors Maclaughlin, David T.; Seifer, David B.

Agent Spruson & Ferguson

Pub. Number AU-B-2002324756

PCT Number PCT/US02/26605

PCT Pub. Number WO2003/016514

Priority 60/313,545 20.08.01 US

Filing date 20 August 2002

Wipo publication date 3 March 2003

Acceptance publication date 7 August 2008

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/313,545 20.08.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002324756

27 May 2004 Amendment Made

  The nature of the amendment is: Add the co-applicant/patentee The General Hospital Corporation

7 August 2008 Application Accepted

  Published as AU-B-2002324756

5 March 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002324757-Method and apparatus for article authentication

2002324755-COMBINED MOTOR DRIVE AND CURRENT SENSING CIRCUIT